Trial Site Detail
Drug: |
BEZ235 + MEK162 |
|||
|---|---|---|---|---|
Trial: |
Safety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor Patients |
|||
| Conditions: | Solid Tumors | |||
Trial Status: |
Ongoing, but not recruiting |
|||
Princess Margaret Hospital610 University Ave |
Principal Investigator: |
Philippe Bedard, MD |
|---|---|
Contact: |
Philippe Bedard, MD +1-4616-946-4534 philippe.bedard@uhn.on.ca |
Activation Status of this Site: |
Not yet activated |
Notes about this Site: |
|
Princess Margaret Hospital Website: |
http://www.uhn.ca/index.asp |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.